Commentaries

CEO commentaries

Peter Egelberg, CEO

Redefining aging with HoloMonitor

By studying a primitive form of bacteria researchers at Queensland University of Technology in Australia have developed a new drug that has the potential to dramatically slow the aging process. Using HoloMonitor the researchers could see how old and damaged cells became young again. The promising results were recently reported by Australian television.

Read more

The Scientific Role of Commercialization

To transform an invention to a product that can be purchased by any scientist is the often unappreciated but crucial role of commercializing enterprises. This was the underlying theme of my presentation at SPIE 2018, “The evolution of Phase Holographic Imaging from a research idea to publicly traded company”.

Read more

Leap of Understanding

The special issue and the increasing number of scientific publications by HoloMonitor customers, and others, leave no room for doubt. Label-free time-lapse cytometry has begun to fulfill its promise to medical science — a leap of understanding.

Read more

Scale Matters

Metastases are believed to originate from a rare type of tumor cells known as cancer stem cells. A combined tool for identifying and studying rare cells would provide cancer researchers with new information to better under­stand the nature of cancer stem cells, and hopefully allow them to develop treatments against these rare and deadly cells.

Read more

The Label-free Promise

To transform an invention to a product that can be purchased by any scientist is the often unappreciated but crucial role of commercializing enterprises. This was the underlying theme of my presentation at SPIE 2018, “The evolution of Phase Holographic Imaging from a research idea to publicly traded company”.

Read more

Life is a mess

In our daily lives, we all know how important it is to plan ahead to avoid a future mess. Ironically, we ourselves are such a future mess.

Read more